38 results
Page 2 of 2
6-K
13q1tnq shp04m8
13 Dec 22
Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
7:00am
6-K
EX-99.1
5hwz2luutd
30 Nov 22
Current report (foreign)
6:28am
6-K
EX-99.1
dx2bxl
27 Oct 22
Current report (foreign)
6:01am
6-K
EX-99.1
afzzahi
4 Aug 22
Current report (foreign)
6:07am
6-K
EX-99.1
2tt8r32x djhgt
28 Jul 22
Current report (foreign)
6:09am
6-K
w9f tlyqtypujp
11 Jul 22
Current report (foreign)
6:05am
6-K
EX-99.1
isyqb1ika4 tlh9
31 May 22
Current report (foreign)
6:14am
6-K
EX-99.1
n62jkd3 dm9wbcba1vf
31 May 22
Current report (foreign)
6:07am
6-K
gjjgop7rfagq5fe cji6
1 Nov 21
Current report (foreign)
6:04am
6-K
ij2 vxgp64
19 Jul 21
Current report (foreign)
6:02am
6-K
EX-99.1
ml7z6r0v7uswe
29 Jun 21
Current report (foreign)
7:38am
6-K
EX-99.1
61gnkx
28 May 21
Current report (foreign)
6:01am
6-K
w44y18 80j
11 May 21
Current report (foreign)
6:08am
6-K
EX-99.1
869r7s10a3ia 2bm3
17 Dec 20
Current report (foreign)
6:01am
6-K
xsh98mizzd2wujx9p3y
14 Jan 20
Current report (foreign)
6:56am
6-K
EX-99.1
8099fsy7ce7
10 Jan 20
Better Health, Brighter Future 2019 SUSTAINABLE VALUE REPORT Takeda Pharmaceutical Company Limited
6:36am